We, at Srimath Pharmaceuticals Healthcare expertise to maintain the Quality ,efficacy in all our products which we supply in the global market. Our quality Team will always monitors by doing frequent quality audits and ensures that our manufacturers follow the Regulatory and quality systems as per global requirements. We do supply all of our pharmaceutical Active ingredients and products of global quality standards at best competitive prices to several companies all over the world. We supply the material from various Indian good manufacturing facilities, approved by prominent regulatory bodies like; Japan, Korea Europe,brazil & USA

Our APIs and pharmaceutical product portfolio consists of more than 300 catering as per our customer needs. We are specialized to cater the customer specification needs in various therapeutic products These includes Anti-Infectives, Cardiovascular, Anti—Diabetic, Antibiotics, Antipsychotic, Anti-inflammatory, Anti-Cancer, Anti- Ulcerative, Anaesthetic, Anti-Asthmatic, Antidiarrhoeal, Antidepressants, Antifungal, Antiparkinson, Antitubercular, Erectile Dysfunction, Ophthalmic, Urologicals, etc.

We are engaged in supplying and exporting Active pharmaceutical ingredients (API). We offering suburb quality range of active pharmaceutical ingredients (API) in competitive prices. API Quality has always been our prime concern and we take measure to maintain the qualitative standards. We ensure that the client have no complaints regarding the quality of Pharmaceutical API, we serve them. Keeping in mind the variegated requirements of clients, these Pharmaceutical API are formulated at our end to attain their maximum contentment. Moreover, we ensure to dispatch our range on-time to the client's destination. The Company intends to manufacture Tablets, Capsules and Liquid orals and present the same in palatable manner by way of attractive Strip Packing, Blister Packing, Alu-Alu Blister packing and by way Glass and PET Bottles.

DISCLAIMER:Products under Patent for Research and Development and/or for experimental use and not for commercialization.Sale of the products is limited to those exempted under Section 107A(a) of the Patents Act. 1970 in India.Under 35 U.S. code § 271(e)(1) in USA and under EC Directives 2001/82/EC (as amended by Directive 2004/28/EC) and 2001/83/EC (as Emended by Directives 2002/98/EC, 2003/63/EC and 2004/27/EC) in European Union and such similar statutes as may be in force/applicable in various other territories/countries.